Tg Therapeutics TGTX
NASDAQ TGTX
$55.78 -0.41 (-0.73%)
At close: Sep 30, 2026 · 4:00 PM EDT

Tg Therapeutics (TGTX) Receivables - Other (2010)

Updated

Tg Therapeutics (TGTX) recorded Receivables - Other of $244,479 in Q4 2010.

Analysis

Tg Therapeutics (TGTX) Receivables - Other (2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tg Therapeutics 8.54 Bn 7.93 Bn 199.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 244,479.00
API Access

Tg Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TGTX&period=max&api_key=YOUR_API_KEY